Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03954886 · ClinicalTrials.gov registry record · NA

Defocus Induced Changes on Choroidal Thickness

A NA study of Induced Defocus to the Retina, sponsored by University of Houston.

Completed
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT03954886: Completed NA study of Induced Defocus to the Retina, sponsored by University of Houston.

NCT03954886 is a NA study of Induced Defocus to the Retina that has completed, run by University of Houston. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03954886, a NA study of Induced Defocus to the Retina, has completed, sponsored by University of Houston.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

The goals of this study are to assess the short-term (10-60 minutes) effects of different magnitudes of myopic and hyperopic optical defocus on the transient thickness of the choroid in children and adults, as well as to assess the recovery period. Choroidal thickness will be measured non-invasively following 10-60 minutes of monocular exposure to -5 diopters to +5 diopters of optical defocus induced by spectacle lenses. The hypothesis is that choroidal thickness will increase with increasing myopic defocus and decrease with increasing hyperopic defocus. The relationship between the magnitude of defocus and the magnitude and direction of choroidal thickness change will be assessed.

Primary Outcome

Changes in choroidal thickness following induced myopic defocus

Interventions

  • DEVICE Plus powered optical lens

Study Locations (1)

Texas

  • University of Houston College of Optometry - Houston

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2018-05-15
Est. Completion 2021-12-31
Phase NA
University of Houston

64 total trials

What the finished NCT03954886 record still lists

NCT03954886 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Induced Defocus to the Retina appearing as the primary indexed condition, and to 1 intervention - of which Plus powered optical lens is the first listed.

NCT03954886 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03954886 about?

NCT03954886 is a clinical study titled "Defocus Induced Changes on Choroidal Thickness". The goals of this study are to assess the short-term (10-60 minutes) effects of different magnitudes of myopic and hyperopic optical defocus on the transient thickness of the choroid in children and adults, as well as to assess the recovery period. Choroidal thickness will be measured non-invasively...

What is the current status of trial NCT03954886?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2018-05-15. Estimated completion is 2021-12-31.

What conditions does trial NCT03954886 study?

This clinical trial studies the following conditions: Induced Defocus to the Retina.

What interventions are being tested in trial NCT03954886?

The interventions under investigation include: Plus powered optical lens (DEVICE).

Who is sponsoring clinical trial NCT03954886?

This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03954886 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT03954886's enrollment target sits among peer trials

48 1381st of 2000 higher than 601 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03954886, the US trial registry maintained by the National Library of Medicine. NCT03954886 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.